Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity)
Clinical trial NCT00124748 · TERMINATED
Trial details
- NCT number
- NCT00124748
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2010-11-01
- Enrollment
- 476
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.